• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用双层选择方法鉴定早期非小细胞肺癌的预后基因和基因集。

Identification of prognostic genes and gene sets for early-stage non-small cell lung cancer using bi-level selection methods.

机构信息

Center for Applied Statistical Research, School of Mathematics, Jilin University, 2699 Qianjin Street, Changchun, Jilin, 130012, China.

Division of Clinical Research, First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin, 130021, China.

出版信息

Sci Rep. 2017 Apr 7;7:46164. doi: 10.1038/srep46164.

DOI:10.1038/srep46164
PMID:28387364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5384004/
Abstract

In contrast to feature selection and gene set analysis, bi-level selection is a process of selecting not only important gene sets but also important genes within those gene sets. Depending on the order of selections, a bi-level selection method can be classified into three categories - forward selection, which first selects relevant gene sets followed by the selection of relevant individual genes; backward selection which takes the reversed order; and simultaneous selection, which performs the two tasks simultaneously usually with the aids of a penalized regression model. To test the existence of subtype-specific prognostic genes for non-small cell lung cancer (NSCLC), we had previously proposed the Cox-filter method that examines the association between patients' survival time after diagnosis with one specific gene, the disease subtypes, and their interaction terms. In this study, we further extend it to carry out forward and backward bi-level selection. Using simulations and a NSCLC application, we demonstrate that the forward selection outperforms the backward selection and other relevant algorithms in our setting. Both proposed methods are readily understandable and interpretable. Therefore, they represent useful tools for the researchers who are interested in exploring the prognostic value of gene expression data for specific subtypes or stages of a disease.

摘要

与特征选择和基因集分析相反,双水平选择是一个不仅选择重要基因集,而且选择这些基因集中重要基因的过程。根据选择的顺序,双水平选择方法可以分为三类 - 前向选择,首先选择相关的基因集,然后选择相关的个体基因;后向选择则采用相反的顺序;以及同时选择,通常借助惩罚回归模型同时执行这两个任务。为了测试非小细胞肺癌 (NSCLC) 特定亚型的预后基因是否存在,我们之前提出了 Cox-filter 方法,该方法检查患者诊断后生存时间与特定基因、疾病亚型及其交互项之间的关联。在这项研究中,我们进一步将其扩展到进行前向和后向双水平选择。使用模拟和 NSCLC 应用程序,我们证明在我们的设置中,前向选择优于后向选择和其他相关算法。这两种方法都易于理解和解释。因此,它们是对探索特定亚型或疾病阶段的基因表达数据预后价值感兴趣的研究人员的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c97/5384004/968d868e11d0/srep46164-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c97/5384004/3567d3769d35/srep46164-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c97/5384004/968d868e11d0/srep46164-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c97/5384004/3567d3769d35/srep46164-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c97/5384004/968d868e11d0/srep46164-f2.jpg

相似文献

1
Identification of prognostic genes and gene sets for early-stage non-small cell lung cancer using bi-level selection methods.采用双层选择方法鉴定早期非小细胞肺癌的预后基因和基因集。
Sci Rep. 2017 Apr 7;7:46164. doi: 10.1038/srep46164.
2
Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data.利用基因组和临床数据鉴定非小细胞肺癌主要亚型的预后生物标志物。
J Cancer Res Clin Oncol. 2020 Nov;146(11):2743-2752. doi: 10.1007/s00432-020-03318-3. Epub 2020 Jul 14.
3
Identification of monotonically differentially expressed genes for non-small cell lung cancer.鉴定非小细胞肺癌中呈单调差异表达的基因。
BMC Bioinformatics. 2019 Apr 11;20(1):177. doi: 10.1186/s12859-019-2775-8.
4
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.非小细胞肺癌的生物标志物发现:整合基因表达谱分析、荟萃分析和组织微阵列验证。
Clin Cancer Res. 2013 Jan 1;19(1):194-204. doi: 10.1158/1078-0432.CCR-12-1139. Epub 2012 Oct 2.
5
High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1.miR-493-5p的高表达通过靶向癌基因ITGB1与非小细胞肺癌的临床预后呈正相关。
Oncotarget. 2017 Jul 18;8(29):47389-47399. doi: 10.18632/oncotarget.17650.
6
Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.PAX6通过启动子甲基化下调与非小细胞肺癌的不良预后相关。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11452-7. eCollection 2015.
7
Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.联合分析确定了六个与非小细胞肺癌向小细胞肺癌恶性程度增加相关的基因。
Tumour Biol. 2016 Feb;37(2):2193-207. doi: 10.1007/s13277-015-3938-5. Epub 2015 Sep 9.
8
Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter.使用基于Cox模型的筛选方法对早期肺腺癌和肺鳞癌患者中组织学亚型特异性预后特征的存在情况进行检测。
Biol Direct. 2015 Apr 7;10:15. doi: 10.1186/s13062-015-0051-z.
9
Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.整合素α6β4表达升高与非小细胞肺癌的静脉侵犯及总生存期缩短相关。
Hum Pathol. 2016 Aug;54:174-83. doi: 10.1016/j.humpath.2016.04.003. Epub 2016 Apr 20.
10
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.一种针对早期非小细胞肺癌的富含免疫反应的72基因预后特征。
Clin Cancer Res. 2009 Jan 1;15(1):284-90. doi: 10.1158/1078-0432.CCR-08-1258.

引用本文的文献

1
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.ECE2 是一个与 m6A 修饰相关的预后生物标志物,参与肺腺癌的免疫浸润。
Front Endocrinol (Lausanne). 2022 Oct 10;13:1013238. doi: 10.3389/fendo.2022.1013238. eCollection 2022.
2
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.Cox筛选方法为两种人类癌症确定了各自的亚型特异性lncRNA预后特征。
BMC Med Genomics. 2020 Feb 5;13(1):18. doi: 10.1186/s12920-020-0691-4.
3
A DNA methylation signature to improve survival prediction of gastric cancer.

本文引用的文献

1
Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression.高维生存回归中的无偏预测与特征选择
J Comput Biol. 2016 Apr;23(4):279-90. doi: 10.1089/cmb.2015.0192. Epub 2016 Feb 19.
2
Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm.使用嵌入式特征选择算法鉴定早期肺腺癌和肺鳞状细胞癌患者的亚型特异性预后基因。
PLoS One. 2015 Jul 30;10(7):e0134630. doi: 10.1371/journal.pone.0134630. eCollection 2015.
3
Pathway and network analysis of cancer genomes.
一种用于改善胃癌生存预测的 DNA 甲基化特征。
Clin Epigenetics. 2020 Jan 20;12(1):15. doi: 10.1186/s13148-020-0807-x.
4
Identification of Monotonically Differentially Expressed Genes for IFN--Treated Multiple Sclerosis Patients.鉴定干扰素治疗多发性硬化症患者中呈单调差异表达的基因。
Biomed Res Int. 2019 Dec 12;2019:5647902. doi: 10.1155/2019/5647902. eCollection 2019.
5
Biomarker potential of repetitive-element transcriptome in lung cancer.肺癌中重复元件转录组的生物标志物潜力
PeerJ. 2019 Dec 19;7:e8277. doi: 10.7717/peerj.8277. eCollection 2019.
6
Incorporating Pathway Information into Feature Selection towards Better Performed Gene Signatures.将通路信息纳入特征选择以获得更好的基因特征表现。
Biomed Res Int. 2019 Apr 3;2019:2497509. doi: 10.1155/2019/2497509. eCollection 2019.
7
Identification of monotonically differentially expressed genes for non-small cell lung cancer.鉴定非小细胞肺癌中呈单调差异表达的基因。
BMC Bioinformatics. 2019 Apr 11;20(1):177. doi: 10.1186/s12859-019-2775-8.
8
Identification of subtype-specific prognostic signatures using Cox models with redundant gene elimination.使用具有冗余基因消除功能的Cox模型鉴定亚型特异性预后特征。
Oncol Lett. 2018 Jun;15(6):8545-8555. doi: 10.3892/ol.2018.8418. Epub 2018 Apr 4.
癌症基因组的通路与网络分析
Nat Methods. 2015 Jul;12(7):615-621. doi: 10.1038/nmeth.3440.
4
Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter.使用基于Cox模型的筛选方法对早期肺腺癌和肺鳞癌患者中组织学亚型特异性预后特征的存在情况进行检测。
Biol Direct. 2015 Apr 7;10:15. doi: 10.1186/s13062-015-0051-z.
5
Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis.多-少:一种用于基因组数据分析中判别分析的简单均值化标记方法。
Bioinformatics. 2014 Nov 1;30(21):3062-9. doi: 10.1093/bioinformatics/btu488. Epub 2014 Jul 23.
6
voom: Precision weights unlock linear model analysis tools for RNA-seq read counts.voom:精确权重为RNA测序读数计数解锁线性模型分析工具。
Genome Biol. 2014 Feb 3;15(2):R29. doi: 10.1186/gb-2014-15-2-r29.
7
Finding consistent disease subnetworks using PFSNet.使用 PFSNet 发现一致的疾病子网络。
Bioinformatics. 2014 Jan 15;30(2):189-96. doi: 10.1093/bioinformatics/btt625. Epub 2013 Nov 28.
8
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.非小细胞肺癌的主要组织学类型在预后相关基因的表达上存在差异。
Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.
9
Pathway index models for construction of patient-specific risk profiles.用于构建患者特定风险概况的途径指数模型。
Stat Med. 2013 Apr 30;32(9):1524-35. doi: 10.1002/sim.5641. Epub 2012 Oct 16.
10
Ten years of pathway analysis: current approaches and outstanding challenges.十年的通路分析:当前方法和突出挑战。
PLoS Comput Biol. 2012;8(2):e1002375. doi: 10.1371/journal.pcbi.1002375. Epub 2012 Feb 23.